至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Engineering a novel biosynthetic pathway in Escherichia coli for the production of caffeine

 RSC Adv. 2017; 
Mengmeng Lia, Ying Suna, Si-an Pana, Wei-wei Denga, Oliver Yub and Zhengzhu Zhang
Products/Services Used Details Operation
Gene Synthesis Polymerase chain reaction (PCR) amplification, purification, digestion, ligation, transformation, and other routine molecular manipulations were performed according to established protocols. The tea caffeine synthase gene TCS1 from Camellie sinensis, the coffee xanthosine methyltransferase gene CaXMT from Coffea arabica, the methionine adenosyltransferase gene SAM2 fromSaccharomyces cerevisiae, the Vitreoscilla hemoglobin gene vgb, and the guanine deaminase gene, GUD1, from Saccharomyces cerevisiae were codon optimized and then commercially synthesized (Genscript Bio Tech Co., Lid, NJ) to permit high-efficiency expression in E. coli. Get A Quote

摘要

Caffeine (Cf, 1,3,7-trimethylxanthine), a major secondary metabolite of many higher plants, is widely used in popular non-alcoholic beverages, and in the pharmaceutical and health industries. Currently, this valuable chemical is mainly manufactured by chemical synthesis. In this study, we developed a novel approach for de novo caffeine production in metabolically engineered Escherichia coli. Xanthine-to-caffeine conversion was first achieved by the expression of a plant-derived gene encoding tea caffeine synthase (TCS1). Caffeine accumulation was then increased using two metabolic strategies: higher-level expression of the target enzymes, and enhancement of xanthine and S-adenosyl-L-methionine biosynthesis.... More

关键词